Goodman Financial Corp raised its position in Nutrien Ltd. (NYSE:NTR - Free Report) by 3.7% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 263,205 shares of the company's stock after acquiring an additional 9,345 shares during the quarter. Nutrien makes up 2.5% of Goodman Financial Corp's portfolio, making the stock its 26th biggest holding. Goodman Financial Corp owned 0.05% of Nutrien worth $11,778,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also bought and sold shares of NTR. Charles Schwab Investment Management Inc. lifted its stake in shares of Nutrien by 10.0% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,742,351 shares of the company's stock worth $83,812,000 after purchasing an additional 157,932 shares during the period. Covea Finance increased its holdings in Nutrien by 21.9% during the fourth quarter. Covea Finance now owns 55,600 shares of the company's stock valued at $2,485,000 after buying an additional 10,000 shares during the last quarter. Clal Insurance Enterprises Holdings Ltd raised its position in Nutrien by 78.8% in the third quarter. Clal Insurance Enterprises Holdings Ltd now owns 2,495,282 shares of the company's stock worth $121,271,000 after acquiring an additional 1,100,000 shares during the period. Wellington Management Group LLP boosted its stake in shares of Nutrien by 12.2% during the 3rd quarter. Wellington Management Group LLP now owns 1,396,887 shares of the company's stock worth $67,200,000 after acquiring an additional 151,596 shares during the last quarter. Finally, Van ECK Associates Corp grew its position in shares of Nutrien by 5.7% during the 4th quarter. Van ECK Associates Corp now owns 1,480,870 shares of the company's stock valued at $66,264,000 after acquiring an additional 80,382 shares during the period. 63.10% of the stock is owned by hedge funds and other institutional investors.
Nutrien Price Performance
Shares of NTR stock traded down $2.34 during trading hours on Tuesday, hitting $50.19. The stock had a trading volume of 3,702,493 shares, compared to its average volume of 1,969,600. The stock's 50-day moving average price is $51.70 and its two-hundred day moving average price is $48.89. Nutrien Ltd. has a one year low of $43.70 and a one year high of $60.87. The stock has a market capitalization of $24.56 billion, a price-to-earnings ratio of 36.64, a PEG ratio of 1.19 and a beta of 0.81. The company has a debt-to-equity ratio of 0.38, a current ratio of 1.27 and a quick ratio of 0.82.
Nutrien (NYSE:NTR - Get Free Report) last issued its quarterly earnings data on Wednesday, February 19th. The company reported $0.28 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.37 by ($0.09). Nutrien had a return on equity of 6.81% and a net margin of 2.62%. The firm had revenue of $5.08 billion for the quarter, compared to analysts' expectations of $5.09 billion. Equities analysts forecast that Nutrien Ltd. will post 3.72 EPS for the current year.
Nutrien Cuts Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, April 10th. Shareholders of record on Monday, March 31st will be paid a $0.545 dividend. The ex-dividend date of this dividend is Monday, March 31st. This represents a $2.18 dividend on an annualized basis and a dividend yield of 4.34%. Nutrien's payout ratio is currently 159.12%.
Analyst Ratings Changes
NTR has been the topic of a number of recent research reports. Barclays raised their target price on Nutrien from $56.00 to $59.00 and gave the stock an "equal weight" rating in a report on Wednesday, March 5th. Scotiabank boosted their price objective on Nutrien from $60.00 to $62.00 and gave the company a "sector outperform" rating in a research note on Monday, February 24th. Piper Sandler raised their target price on shares of Nutrien from $58.00 to $63.00 and gave the stock an "overweight" rating in a research note on Monday, January 27th. Raymond James upgraded shares of Nutrien from a "market perform" rating to an "outperform" rating and upped their price target for the stock from $58.00 to $60.00 in a research report on Tuesday, December 3rd. Finally, JPMorgan Chase & Co. upgraded shares of Nutrien from an "underweight" rating to a "neutral" rating and raised their price objective for the company from $40.00 to $50.00 in a research report on Monday, January 13th. Two investment analysts have rated the stock with a sell rating, five have given a hold rating and nine have given a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of "Hold" and an average target price of $60.13.
View Our Latest Analysis on NTR
Nutrien Profile
(
Free Report)
Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.
Further Reading

Before you consider Nutrien, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutrien wasn't on the list.
While Nutrien currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.